Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 6179.

https://doi.org/10.1182/blood-2023-173085

Published: 2023

Journal Articles

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Giuseppe Milone, Salvatore Leotta, Sara Frazzetto, Giulia Giuffrida, Giulio Antonio Milone, Sebastiano Fiore, Benedetta Esposito, Giordana Brunetti, Andrea Spadaro, Maria Grazia Camuglia, Alessandra Cupri

Blood (2023) 142 (Supplement 1): 7005.

https://doi.org/10.1182/blood-2023-172724

Published: 2023

Journal Articles

Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study

Salvatore Leotta, Andrea Duminuco, Antonino Mulè, Stefania Tringali, Elisa Mauro, Calogero Vetro, Cinzia Maugeri, Marina Parisi, Bruno Garibaldi, Nicola Di Renzo, Claudia Romano, Domenico Pastore, Massimo Gentile, Ernesto Vigna, Carmine Selleri, Giuseppe Milone, Uros Markovic

Blood (2022) 140 (Supplement 1): 11854–11855.

https://doi.org/10.1182/blood-2022-166546

Published: 2022

Journal Articles

T-Cell Lymphocyte Kinetics As a Predictive Biomarker of Blinatumomab MRD Response in ALL-B Patients: A Single-Center Prospective Study

Uros Markovic, Andrea Duminuco, Nunziatina Laura Parrinello, Luca Lo Nigro, Elisa Mauro, Calogero Vetro, Marina Parisi, Cinzia Maugeri, Giuseppe Milone, Alessandra Romano, Francesco Di Raimondo, Salvatore Leotta

Blood (2022) 140 (Supplement 1): 11847–11848.

https://doi.org/10.1182/blood-2022-170177

Published: 2022

Journal Articles

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Alessandra Cupri, MD, Salvatore Leotta, MD, Uros Markovic, MD, Maria Grazia Camuglia, PhD, Giulio Antonio Milone, MD, Angelo Curto Pelle, MD, Valerio Leotta, MD, Mary Ann Di Giorgio, MD, Anna Bulla, MD, Di Marco Anna Lia, PhD, Gaetano Moschetti, MD, Giuseppe Milone, MD PhD

Blood (2019) 134 (Supplement_1): 3271.

https://doi.org/10.1182/blood-2019-127120

Published: 2019

Journal Articles

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Blood (2018) 132 (Supplement 1): 3381.

https://doi.org/10.1182/blood-2018-99-110252

Published: 2018

Journal Articles

Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience

Concetta Conticello, Marina Parisi, MD, Salvatore Leotta, Nunziatina Laura Parrinello, Enrica Martino, Valeria Calafiore, Maria Cristina Pirosa, Urosh Markovic, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2018) 132 (Supplement 1): 5669.

https://doi.org/10.1182/blood-2018-99-120105

Published: 2018

Journal Articles

High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality

Giuseppe Milone, MDPhD, Viviana Frontini, Alessandra Cupri, Salvatore Leotta, Annalia DiMarco, Carla Consoli, Luca Scalise, Giuseppe Sapienza, Gaetano Moschetti, Giuseppe Avola, Andrea Spadaro, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 4497.

https://doi.org/10.1182/blood.V130.Suppl_1.4497.4497

Published: 2017

Journal Articles

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Giuseppe Milone, MDPhD, Annalia DiMarco, Giuseppe Sapienza, Salvatore Leotta, Luca Scalise, Carla Consoli, Maria Cristina Pirosa, Alessandra Cupri, Gaetano Moschetti, Maria Grazia Camuglia, Maria Sciacca, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 5098.

https://doi.org/10.1182/blood.V130.Suppl_1.5098.5098

Published: 2017

Journal Articles

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Giuseppe Milone, MD, Massimo Martino, Annalia Di Marco, BS, Salvatore Leotta, MD, Andrea Spadaro, MD, Mara Morelli, MD, Giuseppe Avola, Maria Grazia Camuglia, Alessandra Cupri, MD, Valentina Zammit, MD, Potito Rosario Scalzulli, MD, Calafiore Valeria, MD, Attilio Olivieri, MD, Giovanni Tripepi, PhD

Blood (2015) 126 (23): 4305.

https://doi.org/10.1182/blood.V126.23.4305.4305

Published: 2015

Journal Articles

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Giuseppe Milone, MD, Giuseppe Avola, Maria Grazia Camuglia, Salvatore Leotta, MD, Alessandra Cupri, Andrea Spadaro, MD, Giovanni Tripepi, MD

Blood (2014) 124 (21): 1160.

https://doi.org/10.1182/blood.V124.21.1160.1160

Published: 2014

Journal Articles

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

Giuseppe Milone, MD, Massimo Martino, MD, Potito R Scalzulli, M.D., Andrea Spadaro, MD, Valentina Di Martina, MD, Elena Schinocca, MD, Eleonora Spina, MD, Annalia Di Marco, BS, Alessandra Cupri, Giovanni Tripepi, MD, Salvatore Leotta, MD

Blood (2013) 122 (21): 4509.

https://doi.org/10.1182/blood.V122.21.4509.4509

Published: 2013

Journal Articles

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Giuseppe Milone, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Valeria Pinto, MD, Andrea Spadaro, Rita Lombardo, MD, Giovanni Tripepi, MD

Blood (2011) 118 (21): 4568.

https://doi.org/10.1182/blood.V118.21.4568.4568

Published: 2011

Journal Articles

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Giuseppe Milone, Salvatore Leotta, Giuseppe Avola, Massimo Poidomani, Maria Grazia Camuglia and Andrea Spadaro

Blood (2010) 116 (21): 4563.

https://doi.org/10.1182/blood.V116.21.4563.4563

Published: 2010

Journal Articles

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Blood (2008) 112 (11): 1144.

https://doi.org/10.1182/blood.V112.11.1144.1144

Published: 2008

Journal Articles

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Giuseppe Milone, MD, Benedetto Farsaci, MD, Giuseppe Avola, BD, Salvatore Mercurio, BD, Aurora Strano, BD, Maria Grazia Camuglia, BD, Valeria Pinto, MD, Antonella Privitera, BD, Salvatore Leotta, MD, Massimo Poidomani, MD, Stefania Coppoletta, MD, Elisa Mauro, MD, Pamela Murgano, MD, Katia Battiato, MD, Andrea Spataro, MD, Anna Triolo, MD, Rosario Giustolisi, MD

Blood (2007) 110 (11): 2849.

https://doi.org/10.1182/blood.V110.11.2849.2849

Published: 2007

Journal Articles

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Giuseppe Milone, MD, Valeria Pinto, MD, Salvatore Mercurio, MD, Aurora Strano, MD, Stefania Coppoletta, MD, Benedetto Farsaci, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Rosario Giustolisi, Md

Blood (2006) 108 (11): 5244.

https://doi.org/10.1182/blood.V108.11.5244.5244

Published: 2006

Journal Articles

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti–thymocyte globulin

Maria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, Cornelio Uderzo, Rosanna Scimè, Sandro Dallorso, Anna Locasciulli, Stefano Guidi, Nicola Mordini, Simona Sica, Laura Cudillo, Franca Fagioli, Carmine Selleri, Barbara Bruno, William Arcese, Andrea Bacigalupo, for the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Blood (2006) 107 (10): 4177–4181.

https://doi.org/10.1182/blood-2005-12-4851

Published: 2006

NARROW

Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study

T-Cell Lymphocyte Kinetics As a Predictive Biomarker of Blinatumomab MRD Response in ALL-B Patients: A Single-Center Prospective Study

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience

High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti–thymocyte globulin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only